![](/img/cover-not-exists.png)
Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Samuel R. Denmeade, Blair Egerdie, Gary Steinhoff, Rosemina Merchant, Ralph Abi-Habib, Peter PommervilleVolume:
59
Year:
2011
Language:
english
Pages:
8
DOI:
10.1016/j.eururo.2010.11.024
File:
PDF, 834 KB
english, 2011